PTH

Invesco DWA Healthcare Momentum ETF

Up$83.50
+$0.64
(+0.77%)
As of 11:04:46 AM EDT | 11/15/19  |  Market Open

PTH Trading Data

Open

$83.1

Low Price

$83.1

High Price

$83.5

Previous Last Price

$82.87

Bid Size

$83.5 X 1100

Ask Size

$83.62 X 100

PTH Portfolio Data

AUM

$124,260,000

Shares

1,500

PE Ratio

495.74

Price / Book Ratio

8.14

Expense Ratio

0.6

Net Asset Value

$82.84

Volume

Volume

2,626

Avg. Volume (YDT)

13,997

Dollar Volume

$198,730

Weekly Avg. Volume

5,054

Monthly Avg. Volume

4,829

Quarterly Avg. Volume

6,407

PTH Fund Description

The Invesco DWA Healthcare Momentum ETF is based on the Dorsey Wright Healthcare Technical Leaders Index (DWA Healthcare Technical Leaders Index). The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Index is designed to identify companies that are showing relative strength (momentum), and is composed of at least 30 common stocks from the NASDAQ US Benchmark Index. The Fund and the Index are rebalanced and reconstituted quarterly.

PTH Chart

PTH Summary

Fund Family

Invesco

Tracks This Index

Invesco DWA Healthcare Momentum ETF

Inception Date

2010-12-06

Asset Class

Equity

Asset Class Size

Biotech

PTH Classification

Region (General)

North America

Region (Specific)

US

Sector

Health Care

Equity Index

Leveraged Family

PTH Holdings

Top 10 Holdings

Insulet Corp (PODD)
4.7%
Thermo Fisher Scientific Inc (TMO)
4.47%
Exact Sciences Corp (EXAS)
4.46%
Masimo Corp (MASI)
4.34%
Edwards Lifesciences Corp (EW)
4.16%
DexCom Inc (DXCM)
4.03%
Humana Inc (HUM)
3.59%
ACADIA Pharmaceuticals Inc (ACAD)
3.46%
Becton Dickinson and Co (BDX)
3.32%
Boston Scientific Corp (BSX)
3.25%

Total PTH Holdings

Total Holdings: 45

Insulet Corp (PODD)
4.7%
Thermo Fisher Scientific Inc (TMO)
4.47%
Exact Sciences Corp (EXAS)
4.46%
Masimo Corp (MASI)
4.34%
Edwards Lifesciences Corp (EW)
4.16%
DexCom Inc (DXCM)
4.03%
Humana Inc (HUM)
3.59%
ACADIA Pharmaceuticals Inc (ACAD)
3.46%
Becton Dickinson and Co (BDX)
3.32%
Boston Scientific Corp (BSX)
3.25%
IDEXX Laboratories Inc (IDXX)
3.09%
Repligen Corp (RGEN)
2.94%
Intuitive Surgical Inc (ISRG)
2.78%
Medicines Co/The (MDCO)
2.76%
Zoetis Inc (ZTS)
2.5%
Neurocrine Biosciences Inc (NBIX)
2.45%
West Pharmaceutical Services Inc (WST)
2.41%
ResMed Inc (RMD)
2.36%
Allakos Inc (ALLK)
2.35%
Tandem Diabetes Care Inc (TNDM)
2.28%
Axsome Therapeutics Inc (AXSM)
2.22%
Natera Inc (NTRA)
2.18%
LHC Group Inc (LHCG)
2.11%
Arrowhead Pharmaceuticals Inc (ARWR)
2.1%
Karyopharm Therapeutics Inc (KPTI)
2.02%
Cardiovascular Systems Inc (CSII)
1.87%
Haemonetics Corp (HAE)
1.76%
Integer Holdings Corp (ITGR)
1.61%
Hill-Rom Holdings Inc (HRC)
1.58%
Nevro Corp (NVRO)
1.54%
Medpace Holdings Inc (MEDP)
1.38%
Inspire Medical Systems Inc (INSP)
1.36%
HMS Holdings Corp (HMSY)
1.33%
CONMED Corp (CNMD)
1.31%
Biohaven Pharmaceutical Holding Co Ltd (BHVN)
1.25%
Coherus Biosciences Inc (CHRS)
1.22%
Hanger Inc (HNGR)
1.2%
Krystal Biotech Inc (KRYS)
1.13%
Lannett Co Inc (LCI)
0.99%
G1 Therapeutics Inc (GTHX)
0.9%
CEL-SCI Corp (CVM)
0.84%
Addus HomeCare Corp (ADUS)
0.84%
US Physical Therapy Inc (USPH)
0.84%
Catalyst Pharmaceuticals Inc (CPRX)
0.71%
PowerShares DWA Healthcare Momentum Portfolio ETF (PTH)
0%

PTH Technicals

Alpha

3.44

Beta

1.35

Leverage

Long

Standard Deviation

4.69

PTH Dividends

Dividend Date

2013-12-20

Latest Dividend

0.0341

Annual Dividend

0

Annual Dividend Rate

0

Annual Dividend Yield

1.0E-5

PTH Performance

YTD Return

17.31%

1 Year Return

5.02%

3 Year Return

63.98%

5 Year Return

57.84%

10 Year Return

271.51%

PTH Related Articles

Two Big Factors Hurting Biotech ETFs

Two Big Factors Hurting Biotech ETFs

Exorbitant drug price concerns and a new Trans-Pacific Partnership deal sent biotech stocks and sector exchange traded funds reeling Tuesday.…

© 2019 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions.

Fundamental company data provided by Morningstar and Zacks Investment Research. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.